Call for: 2025 Clinical Breakthroughs
For presentation during Plenary Session 4205:
MDS Keynote Lecture and Clinical Breakthroughs
08:00 - 9:30, October 8, 2025
Submit a Breakthrough
Clinical Breakthrough Presentations are designed to showcase the results of recent clinical trials or scientific breakthroughs that have major significance for the movement disorders field.
Deadline: August 1, 2025
Criteria
The Congress Scientific Program Committee will consider clinical breakthrough abstract proposals for presentation in the 2025 International Congress if they meet the following criteria:
- The topic must be critically important to the clinical/scientific community and/or the public.
- The proposal should provide results on major phase 2 or phase 3 clinical trials, or novel scientific research.
- The proposal must report the main results or outcomes of data or clinical trials that have not been previously presented; major results published or in press but not previously announced or presented at a clinical or scientific meeting will also be considered.
- The study and results reported should be novel (not simply an extension of previously published work) or definitively confirm or refute other critically important work.
All accepted proposals must comply with MDS Guidelines, and final presentations may undergo further review to ensure compliance.
The following types of studies are NOT appropriate for clinical breakthrough abstract presentations and will not be considered:
- Case reports or small series of cases
- Replication studies
- Descriptions of study designs or plans with no presentation of data
- Extensions of previously reported studies
- Qualitative surveys
- Reviews of existing treatments
- Practice reviews
- Rating scale validation
- Research proposals